141 related articles for article (PubMed ID: 38222051)
41. Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference.
Rahman R; Polley MC; Alder L; Brastianos PK; Anders CK; Tawbi HA; Mehta M; Wen PY; Geyer S; de Groot J; Zadeh G; Piantadosi S; Galanis E; Khasraw M
Lancet Oncol; 2023 Apr; 24(4):e161-e171. PubMed ID: 36990614
[TBL] [Abstract][Full Text] [Related]
42. The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology.
Eekers DB; In 't Ven L; Roelofs E; Postma A; Alapetite C; Burnet NG; Calugaru V; Compter I; Coremans IEM; Høyer M; Lambrecht M; Nyström PW; Méndez Romero A; Paulsen F; Perpar A; de Ruysscher D; Renard L; Timmermann B; Vitek P; Weber DC; van der Weide HL; Whitfield GA; Wiggenraad R; Troost EGC;
Radiother Oncol; 2018 Jul; 128(1):37-43. PubMed ID: 29548560
[TBL] [Abstract][Full Text] [Related]
43. Provider-reported challenges and barriers to referring patients to neuro-oncology clinical trials: a report from the Society for Neuro-Oncology member survey.
Rogers JL; Acquaye A; Vera E; Bates A; Wen PY; Armstrong TS
Neurooncol Pract; 2020 Jan; 7(1):38-51. PubMed ID: 32257283
[TBL] [Abstract][Full Text] [Related]
44. Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working group.
Warren KE; Poussaint TY; Vezina G; Hargrave D; Packer RJ; Goldman S; Wen PY; Pollack IF; Zurakowski D; Kun LE; Prados MD; Rutkowski S; Kieran MW
Pediatr Blood Cancer; 2013 Sep; 60(9):1397-401. PubMed ID: 23625747
[TBL] [Abstract][Full Text] [Related]
45. Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.
Chuntova P; Chow F; Watchmaker PB; Galvez M; Heimberger AB; Newell EW; Diaz A; DePinho RA; Li MO; Wherry EJ; Mitchell D; Terabe M; Wainwright DA; Berzofsky JA; Herold-Mende C; Heath JR; Lim M; Margolin KA; Chiocca EA; Kasahara N; Ellingson BM; Brown CE; Chen Y; Fecci PE; Reardon DA; Dunn GP; Liau LM; Costello JF; Wick W; Cloughesy T; Timmer WC; Wen PY; Prins RM; Platten M; Okada H
Neuro Oncol; 2021 Mar; 23(3):356-375. PubMed ID: 33367885
[TBL] [Abstract][Full Text] [Related]
46. Survivorship care planning and implementation in neuro-oncology.
Leeper H; Milbury K
Neuro Oncol; 2018 Nov; 20(suppl_7):vii40-vii46. PubMed ID: 30412260
[TBL] [Abstract][Full Text] [Related]
47. Neuro-oncology practices in Australia: a Cooperative Group for Neuro-Oncology patterns of care study.
Chen JY; Hovey E; Rosenthal M; Livingstone A; Simes J
Asia Pac J Clin Oncol; 2014 Jun; 10(2):162-7. PubMed ID: 23714694
[TBL] [Abstract][Full Text] [Related]
48. The spiritual needs of neuro-oncology patients from patients' perspective.
Nixon A; Narayanasamy A
J Clin Nurs; 2010 Aug; 19(15-16):2259-370. PubMed ID: 20529167
[TBL] [Abstract][Full Text] [Related]
49. Towards gender equity in emergency medicine: a position statement from the CAEP Women in Emergency Medicine committee.
Sheppard G; Pham C; Nowacki A; Bischoff T; Snider C
CJEM; 2021 Jul; 23(4):455-459. PubMed ID: 33709250
[TBL] [Abstract][Full Text] [Related]
50. The position of the neurologist in neuro-oncology.
Grisold W; Heimans JJ; Postma TJ; Grant R; Soffietti R;
Eur J Neurol; 2002 May; 9(3):201-5. PubMed ID: 11985627
[TBL] [Abstract][Full Text] [Related]
51. Mining-Guided Machine Learning Analyses Revealed the Latest Trends in Neuro-Oncology.
Hana T; Tanaka S; Nejo T; Takahashi S; Kitagawa Y; Koike T; Nomura M; Takayanagi S; Saito N
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30717468
[TBL] [Abstract][Full Text] [Related]
52. Machine Learning in Neuro-Oncology: Can Data Analysis From 5346 Patients Change Decision-Making Paradigms?
Sarkiss CA; Germano IM
World Neurosurg; 2019 Apr; 124():287-294. PubMed ID: 30684706
[TBL] [Abstract][Full Text] [Related]
53. An overview of neuro-oncology research and practice in Iran, three years with the NOSC initiative.
Haddad P; Shazadi S; Samiei F; Kharrazi HH; Tabatabaeefar M; Rakhsha A; Faranoosh M; Torabi-Nami M; Dadras A; Liaghi A; Nafarieh L
Int J Clin Exp Med; 2015; 8(3):3946-55. PubMed ID: 26064296
[TBL] [Abstract][Full Text] [Related]
54. The landscape of neuro-oncology in East Africa: a review of published records.
Haizel-Cobbina J; Chen JW; Belete A; Dewan MC; Karekezi C
Childs Nerv Syst; 2021 Oct; 37(10):2983-2992. PubMed ID: 34468839
[TBL] [Abstract][Full Text] [Related]
55. [Challenges and future perspectives in neuro-oncology].
Tabatabai G; Weller M
Nervenarzt; 2019 Jun; 90(6):594-600. PubMed ID: 31073670
[TBL] [Abstract][Full Text] [Related]
56. Differentiating sex and gender in health research to achieve gender equity.
Kaufman MR; Eschliman EL; Karver TS
Bull World Health Organ; 2023 Oct; 101(10):666-671. PubMed ID: 37772198
[TBL] [Abstract][Full Text] [Related]
57. ASO Author Reflections: Advancing Racial Diversity and Gender Equity in Surgical Oncology Training: Addressing Imbalances and Building Inclusion.
Didier AJ; Sutton JM
Ann Surg Oncol; 2023 Oct; 30(11):6835-6836. PubMed ID: 37378846
[No Abstract] [Full Text] [Related]
58. US Food and Drug Administration regulatory updates in neuro-oncology.
Mehta GU; Barone AK; Bradford D; Larkins E; Kim J; Pai-Scherf L; Jaigirdar A; Shah M; Wedam S; Amiri-Kordestani L; Theoret MR; Pazdur R; Beaver JA; Singh H
J Neurooncol; 2021 Jul; 153(3):375-381. PubMed ID: 34156585
[TBL] [Abstract][Full Text] [Related]
59. Towards gender equity in artificial intelligence and machine learning applications in dermatology.
Lee MS; Guo LN; Nambudiri VE
J Am Med Inform Assoc; 2022 Jan; 29(2):400-403. PubMed ID: 34151976
[TBL] [Abstract][Full Text] [Related]
60. [Introduction to multidisciplinarity in neuro-oncology in Lebanon: First Annual Day of Neuro-Oncology].
Kourie HR; Eid R; Kesserouany C; Abadjian G; Kattan J
Bull Cancer; 2018 Mar; 105(3):327-328. PubMed ID: 29455871
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
